CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: Assessment of GRT6005 in Painful Osteoarthritis of the Knee [Phase 2]
Summary
Phase 2 clinical trial update for GRT6005 in osteoarthritis of the knee has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tris Pharma, Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED